Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway Collapse During Sleep in Patients With Obstructive Sleep Apnoea. (IPOSAT)
Obstructive Sleep Apnea
About this trial
This is an interventional treatment trial for Obstructive Sleep Apnea
Eligibility Criteria
Inclusion Criteria:
- Adult (≥ 40 years old)
- Confirmed diagnosis of OSA (AHI ≥ 5)
- Referred for MAA therapy
- Must be able to understand, read and write English; with the assistance of a translator
Exclusion Criteria:
- Insufficient teeth for MAA fabrication
- Poor dental and/or periodontal health
- Symptomatic Temporomandibular Disorder (TMD)
- Previously used an MAA
- Patients with Epilepsy
Sites / Locations
- Royal London Dental HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention Care Group
Standardized Care Group
The Intervention care group will receive the Mandibular Advancement Appliance (MAA) or the anti-snoring mouthguard. Additionally, they will also receive special support in the form of behaviour change interventions. The behavior change interventions consist of motivational interviewing, will be shown a video highlighting the negative consequences of sleep apnoea. Booster calls at week 3,6, 18 and 12 for verbal encouragement and to resolve any technical problems with the device. Participants will be asked to complete questionnaires regarding their personality, socio-economic status, social support and quality of sleep and life.
The standardized care group will only receive the Mandibular Advancement Appliance (MAA) or the anti-snoring mouthguard along with routine care and will be called for follow up at 3rd and 6th month of treatment to assess their use and to resolve any technical problems with the device. Participants will be asked to complete questionnaires regarding their personality, socio-economic status, social support and quality of sleep and life at the initial visit and subsequent follow-up.